BusinessApogee Therapeutics CEO Michael Henderson Sells $1.64 Million in Stock
Michael Henderson, CEO of Apogee Therapeutics, has sold $1.64 million worth of company stock. The transaction reflects a significant insider sale by the company's top executive.
Investing India·




